MedTrace Logo

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

NCT03322176 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-01-23

No results posted yet for this study

Summary

Increase surveillance for LYNCH Syndrome

Conditions

Interventions

OTHER

Genetic testing

LYNCH genetic testing

Sponsors & Collaborators

  • PAS Research Services

    collaborator OTHER

  • Data Collection Analysis Business Management

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-17
Primary Completion
2020-10-17
Completion
2020-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03322176 on ClinicalTrials.gov